Geoffroy Billard
Responsable contrôle qualité at Crossject | Dijon, Bourgogne-Franche-Comté, France
Geoffroy Billard’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Geoffroy Billard serves as the Quality Control Manager at Crossject, an emerging specialty pharmaceutical company operating across France and the United States. Educated at Nantes Université, he oversees quality assurance protocols within an organization actively developing the ZEPIZURE® epilepsy rescue therapy and its accompanying ZENEO® needle-free delivery platform. His operational leadership directly supports the firm’s clinical progression, notably enabling the recent award of a sixty-million-dollar development contract from the U.S. Biomedical Advanced Research and Development Authority.
BEST APPROACH TO REACH Geoffroy Billard
Initiate contact through LinkedIn by sending a concise direct message that acknowledges his quality control oversight at Crossject and proposes a targeted discussion regarding pharmaceutical supply chain partnerships or specialized regulatory hiring needs.
Nantes Université, Dess, August 1999 to August 2026
Université Marie et Louis Pasteur, DUT chimie, August 1997 to August 1999
Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE® is based on the Company’s award-winning needle-free autoinjector ZENEO®, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Company’s other products in development include rescue therapies for allergic shocks, adrenal insufficiencies, opioid overdose and asthma attacks.
Discover more about Crossject
Responsable Ingénierie des Facteurs Humains chez Crossject
Responsable Ingénierie des Facteurs Humains at Crossject
(September 2006 – Present)
Ingénieur apprenti chez Crossject
Assistant Chef de Projet Industriel at Crossject
(September 2023 – Present)
Director of Purchasing
Directeur des achats et Directeur des Affaires Juridiques at CROSSJECT
(Apr 2025 – Present)
Crossject Vice President Global- BD&L- Clinically proven IM and SC needle-free auto-injector platform, ZENEO and portfolio. Please reach out to schedule a meeting during the J.P. Morgan healthcare conference.
Vice President Global BD&L at CROSSJECT
(Sep 2020 – Present)
Chercheuse d idées pour aller tous mieux
Commercialiser un système d’administration de médicaments sans aiguille
COO at Crossject
Specialty Pharma: we design, develop and will commercialize pharmaceutical drug-device combinations using the Zeneo needle-free auto-injector innovation. Positive clinical and human-use development of ZEPIZURE® (epilepsy), with landmark commercial deals, including with the US...
What is Geoffroy Billard email address?
Email Geoffroy Billard at [email protected] and [email protected]. This email is the most updated Geoffroy Billard's email found in 2026.
How to contact Geoffroy Billard?
To contact Geoffroy Billard send an email to [email protected] or [email protected]. (updated on July 2026)
What company does Geoffroy Billard work for?
Geoffroy Billard works for Crossject.
What is Geoffroy Billard's role at Crossject?
Geoffroy Billard is Responsable contrôle qualité
What industry does Geoffroy Billard work in?
Geoffroy Billard works in the Pharmaceuticals industry.
